121 related articles for article (PubMed ID: 2046526)
21. Thymidine enhancement of methotrexate and 5-fluorouracil toxicity in cultured human colon carcinoma.
Benz C; Choti M; Newcomer L; Cadman E
Cancer Chemother Pharmacol; 1984; 12(2):104-10. PubMed ID: 6199130
[TBL] [Abstract][Full Text] [Related]
22. The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas.
Houghton JA; Tice AJ; Houghton PJ
Mol Pharmacol; 1982 Nov; 22(3):771-8. PubMed ID: 7155134
[TBL] [Abstract][Full Text] [Related]
23. Relationship between antitumor effect and metabolites of 5-fluorouracil in combination treatment with 5-fluorouracil and guanosine in ascites sarcoma 180 tumor system.
Iigo M; Kuretani K; Hoshi A
Cancer Res; 1983 Dec; 43(12 Pt 1):5687-94. PubMed ID: 6640523
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the fluorodihydrouracil substituent in 5-fluorouracil-containing Escherichia coli transfer RNA.
Horowitz J; Cotten ML; Hardin CC; Gollnick P
Biochim Biophys Acta; 1983 Oct; 741(1):70-6. PubMed ID: 6351924
[TBL] [Abstract][Full Text] [Related]
25. [The mechanism of biochemical modulation in methotrexate/5-fluorouracil sequential chemotherapy].
Iba T; Yagi Y; Kidokoro A; Fukunaga M; Uchida J
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2591-4. PubMed ID: 7979418
[TBL] [Abstract][Full Text] [Related]
26. Fluorouracil catabolism in the combination treatment of cyclophosphamide, methotrexate and fluorouracil.
De Bruijn EA; Van der Heyden SA; Gheuens EE; Maes RA
Jpn J Cancer Res; 1992 Oct; 83(10):1102-7. PubMed ID: 1452462
[TBL] [Abstract][Full Text] [Related]
27. Biochemical modulation of 5-fluorouracil with leucovorin or delayed uridine rescue. Correlation of antitumor activity with dosage and FUra incorporation into RNA.
Nord LD; Stolfi RL; Martin DS
Biochem Pharmacol; 1992 Jun; 43(12):2543-9. PubMed ID: 1378737
[TBL] [Abstract][Full Text] [Related]
28. Effect of L-histidinol on the metabolism of 5-fluorouracil in the BALB/c x DBA/8 F1 murine tumor system.
Sawyer RC; Stolfi RL; Martin DS
Cancer Res; 1988 Dec; 48(23):6664-8. PubMed ID: 2460227
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant postoperative chemotherapy with 5-fluorouracil and methotrexate: effect of schedule of administration on metastasis of 13762 mammary adenocarcinoma.
Lee YT; Khwaja TA
J Surg Oncol; 1977; 9(5):469-79. PubMed ID: 592846
[TBL] [Abstract][Full Text] [Related]
30. Critical modulation by thymidine and hypoxanthine of sequential methotrexate-5-fluorouracil synergism in murine L1210 cells.
Piper AA; Nott SE; Mackinnon WB; Tattersall MH
Cancer Res; 1983 Nov; 43(11):5101-5. PubMed ID: 6616448
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological evaluation of experimental isolated liver perfusion and hepatic artery infusion with 5-fluorouracil.
de Brauw LM; Marinelli A; van de Velde CJ; Hermans J; Tjaden UR; Erkelens C; de Bruijn EA
Cancer Res; 1991 Mar; 51(6):1694-700. PubMed ID: 1998960
[TBL] [Abstract][Full Text] [Related]
32. Modulation of 5-fluorouracil catabolism in isolated rat hepatocytes with enhancement of 5-fluorouracil glucuronide formation.
Sommadossi JP; Gewirtz DA; Cross DS; Goldman ID; Cano JP; Diasio RB
Cancer Res; 1985 Jan; 45(1):116-21. PubMed ID: 3965128
[TBL] [Abstract][Full Text] [Related]
33. Decreased host toxicity in vivo during chronic treatment with 5-flourouracil.
Darnowski JW; Sawyer RC; Stolfi RL; Martin DS; Lau-Cam CA
Cancer Chemother Pharmacol; 1985; 14(1):63-9. PubMed ID: 3965161
[TBL] [Abstract][Full Text] [Related]
34. Metabolites of 2'-fluoro-2'-deoxy-D-glucose detected by 19F magnetic resonance spectroscopy in vivo predict response of murine RIF-1 tumors to 5-fluorouracil.
McSheehy PM; Leach MO; Judson IR; Griffiths JR
Cancer Res; 2000 Apr; 60(8):2122-7. PubMed ID: 10786672
[TBL] [Abstract][Full Text] [Related]
35. Fifty-five percent complete remission of mammary carcinoma in mice with 5-fluorouracil and chloroquine.
Shoemaker JP
Cancer Res; 1978 Sep; 38(9):2700-2. PubMed ID: 679173
[TBL] [Abstract][Full Text] [Related]
36. Failure of L-histidinol to improve the therapeutic efficiency of 5-fluorouracil against murine breast tumors.
Stolfi RL; Sawyer RC; Martin DS
Cancer Res; 1987 Jan; 47(1):16-20. PubMed ID: 3791203
[TBL] [Abstract][Full Text] [Related]
37. [In-vivo 19F-MRS study of 5-fluorouracil (5-FU) metabolism on tumors].
Harada M; Nishitani H; Shirahama T; Koga K; Miura I
Gan To Kagaku Ryoho; 1991 Jan; 18(1):75-80. PubMed ID: 1899014
[TBL] [Abstract][Full Text] [Related]
38. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
Fernandes DJ; Moroson BA; Bertino JR
Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
[TBL] [Abstract][Full Text] [Related]
39. 19F magnetic resonance spectroscopy studies of the metabolism of 5-fluorouracil in murine RIF-1 tumors and liver.
Sijens PE; Huang YM; Baldwin NJ; Ng TC
Cancer Res; 1991 Mar; 51(5):1384-90. PubMed ID: 1997177
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of fluorouracil uptake in human colorectal and gastric cancers by interferon or by high-dose methotrexate: An in vivo human study using noninvasive (19)F-magnetic resonance spectroscopy.
Presant CA; Wolf W; Waluch V; Wiseman CL; Weitz I; Shani J
J Clin Oncol; 2000 Jan; 18(2):255-61. PubMed ID: 10637237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
